Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor–BI mediate HDL-initiated signaling
Chatchawin Assanasen, … , Philip W. Shaul, David L. Silver
Chatchawin Assanasen, … , Philip W. Shaul, David L. Silver
Published April 1, 2005
Citation Information: J Clin Invest. 2005;115(4):969-977. https://doi.org/10.1172/JCI23858.
View: Text | PDF
Article Cardiology

Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor–BI mediate HDL-initiated signaling

  • Text
  • PDF
Abstract

The binding of HDL to scavenger receptor–BI (SR-BI) mediates cholesterol movement. HDL also induces multiple cellular signals, which in endothelium occur through SR-BI and converge to activate eNOS. To determine the molecular basis of a signaling event induced by HDL, we examined the proximal mechanisms in HDL activation of eNOS. In endothelial cells, HDL and methyl-β-cyclodextrin caused comparable eNOS activation, whereas cholesterol-loaded methyl-β-cyclodextrin had no effect. Phosphatidylcholine-loaded HDL caused greater stimulation than native HDL, and blocking antibody against SR-BI, which prevents cholesterol efflux, prevented eNOS activation. In a reconstitution model in COS-M6 cells, wild-type SR-BI mediated eNOS activation by both HDL and small unilamellar vesicles (SUVs), whereas the SR-BI mutant AVI, which is incapable of efflux to SUV, transmitted signal by only HDL. In addition, eNOS activation by methyl-β-cyclodextrin was SR-BI dependent. Studies of mutant and chimeric class B scavenger receptors revealed that the C-terminal cytoplasmic PDZ-interacting domain and the C-terminal transmembrane domains of SR-BI are both necessary for HDL signaling. Furthermore, we demonstrated direct binding of cholesterol to the C-terminal transmembrane domain using a photoactivated derivative of cholesterol. Thus, HDL signaling requires cholesterol binding and efflux and C-terminal domains of SR-BI, and SR-BI serves as a cholesterol sensor on the plasma membrane.

Authors

Chatchawin Assanasen, Chieko Mineo, Divya Seetharam, Ivan S. Yuhanna, Yves L. Marcel, Margery A. Connelly, David L. Williams, Margarita de la Llera-Moya, Philip W. Shaul, David L. Silver

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 1 2 5 3 2 3 4 1 5 7 2 3 6 2 6 6 6 3 1 1 69
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (69)

Title and authors Publication Year
Association of the Platelets to High Density Lipoprotein Cholesterol Ratio and Risk of Heart Disease Events in Middle-Aged and Elderly Chinese Population: A Retrospective Cohort Study Utilizing the CHARLS Database
Huang Y, Hou X, Lv F, Gong Z
Reviews in Cardiovascular Medicine 2025
Ligand-dependent interactions between SR-B1 and S1PR1 in macrophages and atherosclerotic plaques
Bassila C, Kluck GE, Thyagarajan N, Chathely KM, Gonzalez L, Trigatti BL
Journal of lipid research 2024
Exome wide association study for blood lipids in 1,158,017 individuals from diverse populations.
Koyama S, Yu Z, Choi SH, Jurgens SJ, Selvaraj MS, Klarin D, Huffman JE, Clarke SL, Trinh MN, Ravi A, Dron JS, Spinks C, Surakka I, Bhatnagar A, Lannery K, Hornsby W, Damrauer SM, Chang KM, Lynch JA, Assimes TL, Tsao PS, Rader DJ, Cho K, Peloso GM, Ellinor PT, Sun YV, Wilson PW, Program MV, Natarajan P
medRxiv : the preprint server for health sciences 2024
HDL Functions—Current Status and Future Perspectives
Endo Y, Fujita M, Ikewaki K
Biomolecules 2023
HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy
Linton MF, Yancey PG, Tao H, Davies SS
Circulation research 2023
LDL Transcytosis by the Arterial Endothelium-Atherosclerosis by a Thousand Cuts?
Ho TWW, Henry A, Lee WL
Current Atherosclerosis Reports 2023
Inverse Correlation of Cholesterol Efflux Capacity with Peripheral Plaque Volume Measured by 3D Ultrasound.
Noflatscher M, Hunjadi M, Schreinlechner M, Sommer P, Lener D, Theurl M, Kirchmair R, Bauer A, Ritsch A, Marschang P
Biomedicines 2023
Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes.
Denimal D
2023
SR-B1's Next Top Model: Structural Perspectives on the Functions of the HDL Receptor.
Powers HR, Sahoo D
Current Atherosclerosis Reports 2022
HDL and Endothelial Function.
Wu Y, Xu Y, Chen J, Zhao M, Rye KA
Advances in experimental medicine and biology 2022
Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength.
Jones WL, Ramos CR, Banerjee A, Moore EE, Hansen KC, Coleman JR, Kelher M, Neeves KB, Silliman CC, Di Paola J, Branchford B
Platelets 2022
Endothelial Cell Receptors in Tissue Lipid Uptake and Metabolism
NA Abumrad, AG Cabodevilla, D Samovski, T Pietka, D Basu, IJ Goldberg
Circulation research 2021
The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions
J Robert, E Osto, A von Eckardstein
Cells 2021
Structure–function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk
C Gkolfinopoulou, F Soukou, I Dafnis, TF Kellici, D Sanoudou, T Mavromoustakos, E Stratikos, A Chroni
Cellular and Molecular Life Sciences 2020
SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formation
TG Vishnyakova, AV Bocharov, IN Baranova, R Kurlander, SK Drake, Z Chen, M Amar, D Sviridov, B Vaisman, E Poliakov, AT Remaley, TL Eggerman, AP Patterson, CM Maya-Monteiro
PloS one 2020
Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in Apoe -deficient mice
Y Higashi, S Sukhanov, SY Shai, S Danchuk, P Snarski, Z Li, X Hou, MH Hamblin, TC Woods, M Wang, D Wang, H Yu, RJ Korthuis, T Yoshida, P Delafontaine
American journal of physiology. Heart and circulatory physiology 2020
Beta cell secretion of miR-375 to HDL is inversely associated with insulin secretion
LR Sedgeman, C Beysen, MA Solano, DL Michell, Q Sheng, S Zhao, S Turner, MR Linton, KC Vickers
Scientific Reports 2019
Proline residues in scavenger receptor-BI's C-terminal region support efficient cholesterol transport
SC Proudfoot, D Sahoo
Biochemical Journal 2019
A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis
ED Miller, A Dziedzic, J Saluk-Bijak, M Bijak
Nutrients 2019
Scavenger Receptor Class B Type 1 (SR-B1) being a Potential Biomarker for the Diagnosis of Liposarcoma and Associated with the Degree of Differentiation of Liposarcomas
Q Liu, Z Li, H Shang, Q Zhang, X Wang, Y Zhang, Y Wang, Q Li, C Li, C Liu, F Li
Journal of Cancer 2019
Significance of Cholesterol-Binding Motifs in ABCA1, ABCG1, and SR-B1 Structure
AD Dergunov, EV Savushkin, LV Dergunova, DY Litvinov
The Journal of Membrane Biology 2018
Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
T Paavola, S Kuusisto, M Jauhiainen, S Kakko, T Kangas-Kontio, J Metso, P Soininen, M Ala-Korpela, R Bloigu, ML Hannuksela, MJ Savolainen, T Salonurmi, L Calabresi
PloS one 2017
SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis
MR Linton, H Tao, EF Linton, PG Yancey
Trends in Endocrinology & Metabolism 2017
Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin
JS Rink, S Yang, O Cen, T Taxter, KM McMahon, S Misener, A Behdad, R Longnecker, LI Gordon, CS Thaxton
Molecular Pharmaceutics 2017
Cholesterol trafficking and raft-like membrane domain composition mediate scavenger receptor class B type 1-dependent lipid sensing in intestinal epithelial cells
E Morel, S Ghezzal, G Lucchi, C Truntzer, JP de Barros, F Simon-Plas, S Demignot, C Mineo, PW Shaul, A Leturque, M Rousset, V Carrière
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2017
Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol LoweringHighlights
P Yu, T Xiong, CB Tenedero, P Lebeau, R Ni, ME MacDonald, PL Gross, RC Austin, BL Trigatti
Arteriosclerosis, thrombosis, and vascular biology 2017
Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease
R Pal, Q Ke, GA Pihan, A Yesilaltay, ML Penman, L Wang, C Chitraju, PM Kang, M Krieger, O Kocher
American journal of physiology. Heart and circulatory physiology 2016
S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization
MH Lee, KM Appleton, HM El-Shewy, MG Sorci-Thomas, MJ Thomas, MF Lopes-Virella, LM Luttrell, SM Hammad, RL Klein
Journal of lipid research 2016
SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer
JL Gutierrez-Pajares, CB Hassen, S Chevalier, PG Frank
Frontiers in pharmacology 2016
High-Density Lipoproteins, Endothelial Function, and Mendelian Randomization
M Westerterp, N Wang, AR Tall
Circulation research 2016
Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in MiceHighlights
M Westerterp, K Tsuchiya, IW Tattersall, P Fotakis, AE Bochem, MM Molusky, V Ntonga, S Abramowicz, JS Parks, CL Welch, J Kitajewski, D Accili, AR Tall
Arteriosclerosis, thrombosis, and vascular biology 2016
Activation of Endothelial Nitric Oxide (eNOS) Occurs through Different Membrane Domains in Endothelial Cells
J Tran, A Magenau, M Rodriguez, C Rentero, T Royo, C Enrich, SR Thomas, T Grewal, K Gaus, IR Nabi
PloS one 2016
Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
LK Mooberry, NA Sabnis, M Panchoo, B Nagarajan, AG Lacko
Frontiers in pharmacology 2016
PDZK1 Prevents Neointima Formation via Suppression of Breakpoint Cluster Region Kinase in Vascular Smooth Muscle
WR Lee, A Sacharidou, E Behling-Kelly, SC Oltmann, W Zhu, M Ahmed, RD Gerard, DY Hui, J Abe, PW Shaul, C Mineo, A Zernecke
PloS one 2015
HDL signaling and protection against coronary artery atherosclerosis in mice.
Trigatti BL, Fuller M
Journal of Biomedical Research 2015
High Density Lipoprotein Stimulated Migration of Macrophages Depends on the Scavenger Receptor Class B, Type I, PDZK1 and Akt1 and Is Blocked by Sphingosine 1 Phosphate Receptor Antagonists
A Al-Jarallah, X Chen, L González, BL Trigatti
PloS one 2014
High-Density Lipoprotein: A Novel Target for Antirestenosis Therapy: HDL and A ntirestenosis T herapy
K Yin, DK Agrawal
Clinical and Translational Science 2014
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
A Rohatgi, A Khera, JD Berry, EG Givens, CR Ayers, KE Wedin, IJ Neeland, IS Yuhanna, DR Rader, JA de Lemos, PW Shaul
New England Journal of Medicine 2014
HDL and endothelial protection
A Tran-Dinh, D Diallo, S Delbosc, LM Varela-Perez, QB Dang, B Lapergue, E Burillo, JB Michel, A Levoye, JL Martin-Ventura, O Meilhac
British Journal of Pharmacology 2013
Scavenger Receptor Class B Type I Is a Plasma Membrane Cholesterol Sensor
S Saddar, V Carriere, WR Lee, K Tanigaki, IS Yuhanna, S Parathath, E Morel, M Warrier, JK Sawyer, RD Gerard, RE Temel, JM Brown, M Connelly, C Mineo, PW Shaul
Circulation research 2013
Inhibition of Mitogen-Activated Protein Kinase Erk1/2 Promotes Protein Degradation of ATP Binding Cassette Transporters A1 and G1 in CHO and HuH7 Cells
V Mulay, P Wood, M Manetsch, M Darabi, R Cairns, M Hoque, KC Chan, M Reverter, A Álvarez-Guaita, KA Rye, C Rentero, J Heeren, C Enrich, T Grewal, X Ai
PloS one 2013
Regulation of signal transduction by HDL
C Mineo, PW Shaul
Journal of lipid research 2013
Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development
C Danilo, JL Gutierrez-Pajares, MA Mainieri, I Mercier, MP Lisanti, PG Frank
Breast Cancer Research 2013
The use of lentinan for treating gastric cancer.
Ina K, Kataoka T, Ando T
Anti-cancer agents in medicinal chemistry 2013
Novel biological functions of high-density lipoprotein cholesterol
C Mineo, PW Shaul
Circulation research 2012
XenomiRs and miRNA homeostasis in health and disease
KW Witwer
RNA biology 2012
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler, Kathrin Heinrich, Lucia Rohrer, Carola Doerries, Meliana Riwanto, Diana M. Shih, Angeliki Chroni, Keiko Yonekawa, Sokrates Stein, Nicola Schaefer, Maja Mueller, Alexander Akhmedov, Georgios Daniil, Costantina Manes, Christian Templin, Christophe Wyss, Willibald Maier, Felix C. Tanner, Christian M. Matter, Roberto Corti, Clement E. Furlong, Aldons J. Lusis, Arnold von Eckardstein, Alan M. Fogelman, Thomas F. Lüscher, Ulf Landmesser
Journal of Clinical Investigation 2011
PON-dering differences in HDL function in coronary artery disease
C Mineo, PW Shaul
Journal of Clinical Investigation 2011
Ras/Mitogen-activated Protein Kinase (MAPK) Signaling Modulates Protein Stability and Cell Surface Expression of Scavenger Receptor SR-BI*
P Wood, V Mulay, M Darabi, KC Chan, J Heeren, A Pol, G Lambert, KA Rye, C Enrich, T Grewal
The Journal of biological chemistry 2011
Stimulatory Effect of β-glucans on Immune Cells
HS Kim, JT Hong, Y Kim, SB Han
Immune Network 2011
Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell Signaling
MB Fessler, JS Parks
Journal of immunology (Baltimore, Md. : 1950) 2011
Update on HDL receptors and cellular cholesterol transport.
Kellner-Weibel G, de la Llera-Moya M
Current Atherosclerosis Reports 2011
Cholesterol Binding and Cholesterol Transport Proteins:
JR Harris
2010
Regulation of Platelet Function by Class B Scavenger Receptors in Hyperlipidemia
A Zimman, EA Podrez
Arteriosclerosis, thrombosis, and vascular biology 2010
Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx: Acute activation of eNOS by statins
R Datar, WH Kaesemeyer, S Chandra, DJ Fulton, RW Caldwell
British Journal of Pharmacology 2010
Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein
K Sato, F Okajima
World journal of biological chemistry 2010
Use of dansyl-cholestanol as a probe of cholesterol behavior in membranes of living cells
H Huang, AL McIntosh, BP Atshaves, Y Ohno-Iwashita, AB Kier, F Schroeder
Journal of lipid research 2010
In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1
O Kocher, G Birrane, K Tsukamoto, S Fenske, A Yesilaltay, R Pal, K Daniels, JA Ladias, M Krieger
The Journal of biological chemistry 2010
Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells
T Kimura, H Tomura, K Sato, M Ito, I Matsuoka, DS Im, A Kuwabara, C Mogi, H Itoh, H Kurose, M Murakami, F Okajima
The Journal of biological chemistry 2009
Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice
A Yesilaltay, K Daniels, R Pal, M Krieger, O Kocher
PloS one 2009
Caveolin-1 mediates endotoxin inhibition of endothelin-1-induced endothelial nitric oxide synthase activity in liver sinusoidal endothelial cells
W Kwok, SH Lee, C Culberson, K Korneszczuk, MG Clemens
American journal of physiology. Gastrointestinal and liver physiology 2009
Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI
O Kocher, M Krieger
Current Opinion in Lipidology 2009
Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1
O Béaslas, C Cueille, F Delers, D Chateau, J Chambaz, M Rousset, V Carrière
PloS one 2009
eNOS Mediates TO90317 Treatment-Induced Angiogenesis and Functional Outcome After Stroke in Mice
J Chen, X Cui, A Zacharek, C Roberts, M Chopp
Stroke; a journal of cerebral circulation 2009
Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI
M Valiyaveettil, N Kar, MZ Ashraf, TV Byzova, M Febbraio, EA Podrez
Blood 2008
Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42
BI Hudson, AZ Kalea, MD Arriero, E Harja, E Boulanger, V D'Agati, AM Schmidt
The Journal of biological chemistry 2008
Influence of PDZK1 on lipoprotein metabolism and atherosclerosis
O Kocher, A Yesilaltay, CH Shen, S Zhang, K Daniels, R Pal, J Chen, M Krieger
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2008
Lipid rafts: dream or reality for cholesterol transporters?
S Orlowski, C Coméra, F Tercé, X Collet
European Biophysics Journal 2007
Reduction of Amyloid Angiopathy and Aβ Plaque Burden after Enriched Housing in TgCRND8 Mice
O Ambrée, U Leimer, A Herring, N Görtz, N Sachser, MT Heneka, W Paulus, K Keyvani
The American Journal of Pathology 2006

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts